Key Financials Snapshot

TTM · Standalone · ₹ in Cr
Market Cap
₹15 Cr.
Stock P/E
15
P/B
1.5
Current Price
₹92
Book Value
₹ 63
Face Value
10
52W High
₹149.9
52W Low
₹ 75.5
Dividend Yield
—

EP Biocomposites Overview

Business

EP Biocomposites Ltd. operates in the plastic products sector, specializing in the development and manufacturing of biocomposite materials and products. Biocomposites are typically engineered materials made from a combination of natural fibers (e.g., wood fiber, agricultural waste) and polymer matrices (both traditional and bio-based plastics). The company's core business model involves producing these sustainable alternatives to traditional plastics and wood, catering to industries looking for greener, lightweight, or specialized material solutions. It makes money by selling these biocomposite raw materials or finished/semi-finished products to its customers in various application areas.

Revenue Mix

Specific revenue mix and segment breakdowns are not publicly available from the given information. However, based on the nature of biocomposites, potential application areas that could constitute revenue segments include:

Building & Construction Materials: Such as decking, fencing, wall panels, or interior components.

Automotive Components: For interior trims, dashboards, or structural elements, aiming for lightweighting and sustainability.

Consumer Goods & Packaging: Durable consumer products or specialized packaging where eco-friendly materials are preferred.

Industrial Applications: Tailored solutions for specific industrial needs requiring unique material properties.

Industry

EP Biocomposites operates within the broader Indian plastic products industry, but specifically targets the niche and growing market for biocomposites and sustainable materials. The industry is characterized by increasing demand for eco-friendly alternatives to conventional plastics, driven by environmental concerns and regulatory pressures. The company is positioned as a provider of advanced, sustainable material solutions, competing not only with traditional plastic manufacturers but also with other bioplastic producers and wood composite providers. Its focus on "biocomposites" implies a specialization in materials that often offer a balance of mechanical properties, cost-effectiveness, and environmental benefits.

MOAT

Given its specialization, potential competitive advantages for EP Biocomposites could include:

Proprietary Formulations & R&D: Expertise in developing unique biocomposite materials with specific performance characteristics (e.g., strength, durability, biodegradability, flame resistance).

Process Technology: Efficient and scalable manufacturing processes for converting raw natural fibers and polymers into high-quality biocomposites.

Niche Market Expertise: Deep understanding of specific application requirements and the ability to tailor solutions for target industries, building strong customer relationships in these specialized areas.

Sustainable Sourcing: Established supply chains for natural fibers, potentially giving an edge in cost or consistency.

Growth Drivers

Increasing Demand for Sustainable Materials: Global and domestic push for eco-friendly products and reduced carbon footprint.

Favorable Regulations: Government policies promoting biodegradable, recyclable, and bio-based materials, and restrictions on single-use plastics.

Material Innovation & Applications: Continuous R&D leading to new biocomposite materials with improved properties and expanding their application across new industries.

Cost Competitiveness: Achieving economies of scale and optimizing processes to make biocomposites more cost-competitive against traditional materials.

Industry Collaboration: Partnerships with major manufacturers in automotive, construction, or consumer goods to integrate biocomposite solutions.

Risks

Raw Material Volatility: Fluctuations in the prices and availability of natural fibers (e.g., wood pulp, agricultural waste) and polymer resins.

Technological Obsolescence: Rapid advancements in material science could lead to new, superior, or more cost-effective alternatives emerging.

Market Acceptance & Adoption: Slower-than-expected adoption of biocomposite products due to perceived performance limitations, higher costs, or lack of awareness among end-users.

Competition: Intense competition from established plastic manufacturers, other bioplastic companies, and composite material producers.

Regulatory Changes: Adverse shifts in environmental regulations or certification standards that could impact product viability or market access.

High R&D Intensity: Significant capital and operational expenditure required for continuous research and development without guaranteed commercial success.

Management & Ownership

As an Indian "Ltd." company with a ticker (EPBIO), it is likely a publicly listed entity or on a path to listing, implying a formal board and management structure. Promoters would typically be the founding individuals or families with significant shareholding and a long-term vision for the company's growth in the biocomposites space. Management quality would ideally be characterized by a strong focus on R&D, manufacturing efficiency, market development, and navigating the complexities of a specialized, evolving industry. In Indian listed companies, promoters often retain a controlling stake.

Outlook

EP Biocomposites Ltd. operates in a promising and strategically important segment within the broader materials industry. The global megatrend towards sustainability and the increasing pressure to reduce reliance on conventional plastics provide a significant tailwind for companies like EP Biocomposites. The company's focus on biocomposites positions it to capitalize on the demand for eco-friendly, performance-driven materials.

However, the outlook is balanced by several challenges. The market for advanced materials is highly competitive and requires continuous innovation, substantial R&D investments, and efficient scaling of production. Fluctuations in raw material costs, the need for consistent product quality, and the ongoing effort to achieve wider market acceptance are critical factors. Success will depend on the company's ability to innovate cost-effectively, secure reliable supply chains, build strong customer relationships in specialized applications, and effectively differentiate its biocomposite solutions from alternative materials.

EP Biocomposites Share Price

Live · BSE · Inception: 2020
₹ | |
Volume
Price

Key Financials — Profit & Loss

₹ in Cr · Standalone · annual

EP Biocomposites Quarterly Results

#(Fig in Cr.)
Net Sales
Other Income
Total Income
Total Expenditure
Operating Profit
Interest
Depreciation
Exceptional Income / Expenses
Profit Before Tax
Provision for Tax
Profit After Tax
Adjustments
Profit After Adjustments
Adjusted Earnings Per Share

EP Biocomposites Profit & Loss

#(Fig in Cr.) Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
Net Sales 1 3 8 7 11 12
Other Income 0 0 0 0 0 0
Total Income 1 3 8 7 12 12
Total Expenditure 1 2 7 6 10 10
Operating Profit 0 0 1 1 2 2
Interest 0 0 0 0 0 0
Depreciation 0 0 0 0 0 0
Exceptional Income / Expenses 0 0 0 0 0 0
Profit Before Tax 0 0 1 1 2 1
Provision for Tax 0 0 0 0 0 0
Profit After Tax 0 0 1 1 1 1
Adjustments 0 0 0 0 0 0
Profit After Adjustments 0 0 1 1 1 1
Adjusted Earnings Per Share 0.8 9.5 6.9 3.4 6.8 6.1

EP Biocomposites Balance Sheet

#(Fig in Cr.) Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Shareholder's Funds 0 0 2 8 10 11
Minority's Interest 0 0 0 0 0 0
Borrowings 0 0 2 1 1 2
Other Non-Current Liabilities 0 0 0 0 -0 -0
Total Current Liabilities 1 1 5 2 4 4
Total Liabilities 1 1 9 12 15 17
Fixed Assets 0 0 0 0 0 0
Other Non-Current Assets 0 0 0 2 2 2
Total Current Assets 1 1 9 9 12 14
Total Assets 1 1 9 12 15 17

EP Biocomposites Cash Flow

#(Fig in Cr.) Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Opening Cash & Cash Equivalents 0 0 0 0 2 1
Cash Flow from Operating Activities 0 0 -4 -1 -1 -0
Cash Flow from Investing Activities 0 0 -0 0 -0 0
Cash Flow from Financing Activities -0 -0 5 3 0 1
Net Cash Inflow / Outflow 0 0 0 2 -1 0
Closing Cash & Cash Equivalent 0 0 0 2 1 2

EP Biocomposites Ratios

# Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Earnings Per Share (Rs) 0.84 9.55 6.87 3.43 6.84 6.13
CEPS(Rs) 0.84 9.55 7.44 4.02 7.44 6.8
DPS(Rs) 0 0 0 0 0 0
Book NAV/Share(Rs) 0.76 10.31 16.97 50.04 56.88 63.01
Core EBITDA Margin(%) 7.6 15.65 17.48 13.71 12.33 14.82
EBIT Margin(%) 7.64 15.79 16.85 14.64 14.06 14.79
Pre Tax Margin(%) 7.59 15.75 14.47 11.42 13.73 11.8
PAT Margin (%) 5.54 12.14 10.04 8.08 10.05 8.59
Cash Profit Margin (%) 5.54 12.15 10.86 9.48 10.93 9.52
ROA(%) 5.71 38.18 15.27 5.49 8.58 6.51
ROE(%) 110.53 172.53 67.88 11.07 12.79 10.23
ROCE(%) 140 222.95 41.82 13.21 15.28 14.24
Receivable days 193.97 58.75 175.34 331.63 237.06 301.79
Inventory Days 71.45 34.74 36.97 56.27 32.72 37.18
Payable days 406.83 142.02 104.49 150.42 100.33 118.43
PER(x) 0 0 0 58.81 20.06 20.13
Price/Book(x) 0 0 0 4.03 2.41 1.96
Dividend Yield(%) 0 0 0 0 0 0
EV/Net Sales(x) -0.11 -0.03 0.64 4.62 2.06 1.84
EV/Core EBITDA(x) -1.46 -0.21 3.6 28.83 13.8 11.71
Net Sales Growth(%) 0 418.92 173.39 -11.52 60.42 4.96
EBIT Growth(%) 0 972.35 191.88 -23.15 54.1 10.36
PAT Growth(%) 0 1036.51 126.09 -28.82 99.57 -10.34
EPS Growth(%) 0 1036.51 -28 -50.16 99.57 -10.34
Debt/Equity(x) 0.09 0 2.06 0.15 0.19 0.28
Current Ratio(x) 1.06 1.39 1.73 4.45 2.84 3.95
Quick Ratio(x) 0.84 0.91 1.49 3.96 2.6 3.55
Interest Cover(x) 144.67 387.83 7.06 4.54 42.11 4.95
Total Debt/Mcap(x) 0 0 0 0.04 0.08 0.14

Growth Rates

Compounded annual
# 1 Year 3 Year 5 Year 10 Year
Sales CAGR +9% +14% +64% —
Operating Profit CAGR 0% +26% — —
PAT CAGR 0% 0% — —
Share Price CAGR -27% -22% — —
ROE Average +10% +11% +55% +64%
ROCE Average +14% +14% +62% +75%

EP Biocomposites Shareholding Pattern

Latest · Jun 2026
100% held
Promoters 70.08 %
FII 0 %
DII (MF + Insurance) 0 %
Public (retail) 29.92 %
# Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026
Promoter 70.0870.0870.0870.0870.0870.0870.0570.0870.0870.08
FII 2.2000000000
DII 0000000000
Public 27.7229.9229.9229.9229.9229.9229.9529.9229.9229.92
Others 0000000000
Total 100100100100100100100100100100

EP Biocomposites Peer Comparison

Plastic Products Edit Columns

EP Biocomposites Quarterly Price

10-year quarterly close · BSE
Show Value Show %

News & Updates

See more…

EP Biocomposites Pros & Cons

Pros

  • Company is almost debt free.

Cons

  • Company has a low return on equity of 11% over the last 3 years.
  • Debtor days have increased from 100.33 to 118.43days.
Want to Start Investing in Top Unlisted Stocks?

Our experts help you choose the right stocks based on performance, risk, and growth potential.

whatsapp